How should I assess a patient presenting with acute unilateral facial weakness for Bell's palsy?

Assessment of Bell's Palsy

Assess patients with acute unilateral facial weakness using a focused history and physical examination to exclude identifiable causes—Bell's palsy is a diagnosis of exclusion requiring rapid onset (<72 hours), complete unilateral facial nerve involvement (including forehead), and absence of other neurologic findings. 1

Key Diagnostic Criteria

Bell's palsy is defined as acute unilateral facial nerve paresis or paralysis with onset in less than 72 hours and without an identifiable cause 1. The diagnosis is fundamentally one of exclusion.

Critical History Elements

Timing and Onset:

• Symptom onset must be rapid, developing over less than 72 hours 1
• Peak weakness typically occurs within 24-72 hours 2
• Symptoms that develop more gradually or progress beyond 72 hours suggest alternative diagnoses

Associated Symptoms to Assess:

• Periauricular pain or numbness (common in Bell's palsy) 2
• Taste disturbance or loss on anterior tongue
• Hyperacusis (increased sensitivity to sound)
• Dry eye or excessive tearing
• Difficulty with oral competence (drooling, difficulty eating)

Red Flags Suggesting Alternative Diagnoses:

• Bilateral facial weakness (extremely rare in Bell's palsy; consider Guillain-Barré syndrome, Lyme disease) 1, 3
• Gradual onset over weeks to months (suggests tumor)
• Recurrent episodes (not typical Bell's palsy)
• Additional neurologic deficits beyond CN VII
• Recent head trauma or ear surgery
• Vesicular rash in ear canal or palate (Ramsay Hunt syndrome)

Physical Examination Components

Facial Nerve Function Assessment:

• Test all branches: forehead wrinkling, eye closure, smile/grimace, lip pursing
• Critical distinction: Bell's palsy affects the forehead (upper motor neuron lesions spare forehead) 4
• Document severity using House-Brackmann grading system (Grade 1-6) 1, 5
• Assess for complete vs incomplete paralysis (impacts prognosis and testing decisions)

Cranial Nerve Examination:

• Examine all other cranial nerves to ensure isolated CN VII involvement
• Any additional cranial nerve deficits exclude Bell's palsy diagnosis 1

Head and Neck Examination:

• Inspect external ear canal and tympanic membrane for vesicles (herpes zoster)
• Palpate parotid gland for masses
• Check for signs of Lyme disease (erythema migrans rash)
• Assess for signs of systemic disease

Eye Examination:

• Test eye closure completeness (critical for eye protection planning)
• Assess corneal reflex
• Look for signs of exposure keratopathy

Testing Recommendations

Routine Laboratory Testing: NOT RECOMMENDED 1

• Do not obtain routine labs in typical Bell's palsy presentations
• Consider selective testing only if history suggests specific etiologies:
  • Lyme serology if endemic area or tick exposure
  • Glucose testing if diabetes risk factors present
  • HIV testing if risk factors present

Diagnostic Imaging: NOT ROUTINELY RECOMMENDED 1

• Do not perform routine MRI or CT for typical Bell's palsy
• Consider imaging only for atypical features:
  • Gradual onset or progression beyond 72 hours
  • Additional neurologic deficits
  • Recurrent facial palsy
  • Bilateral involvement
  • Failure to improve after 3 months 6

Electrodiagnostic Testing:

• Do NOT perform in patients with incomplete facial paralysis 1
• May offer electroneuronography (ENoG) or electromyography (EMG) only in complete facial paralysis for prognostic purposes 1, 6
• Timing: Most useful 3-14 days after onset if performed

Common Diagnostic Pitfalls

Mistaking Central for Peripheral Lesions:

• Stroke spares forehead function (upper motor neuron pattern)
• Bell's palsy affects entire hemiface including forehead
• Any forehead sparing should prompt immediate stroke evaluation

Missing Ramsay Hunt Syndrome:

• Always examine ear canal for vesicles
• May present before rash appears
• Worse prognosis than Bell's palsy; requires antiviral therapy 7

Overlooking Bilateral Involvement:

• Bilateral Bell's palsy is exceedingly rare
• Consider Guillain-Barré syndrome, Lyme disease, sarcoidosis 3

Over-testing Typical Cases:

• The guidelines explicitly recommend against routine labs and imaging 1
• Testing should be reserved for atypical presentations only
• Over-testing delays treatment and increases costs without improving outcomes

Risk Factor Assessment

Higher risk populations include 1:

• Ages 15-45 years (peak incidence)
• Pregnancy (especially third trimester)
• Diabetes mellitus
• Recent upper respiratory infection
• Immunocompromised states

Documentation Requirements

Document clearly:

• Time of symptom onset (critical for treatment window)
• Degree of weakness (complete vs incomplete)
• Forehead involvement (confirms peripheral lesion)
• Eye closure ability (determines urgency of eye protection)
• Absence of other neurologic findings
• House-Brackmann grade if possible 5